It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for sessions on learning the tricks of the trade in preparing a non-confidential deck and executive summary. Experts of the craft will share practical tips on becoming more effective in communicating your story to Angel investors and VCs, increasing your chances of successful fundraising.
Damian Lamb | Co-Founder and Managing Director, Genesys Capital
Mr. Lamb is co-Founder and Managing Director of Genesys Capital. Since co-founding Genesys Capital in 2000, Mr. Lamb has been instrumental in raising over $225 million in venture capital funds, and has been involved in deploying over $155 million in 28 investments. He currently serves on the Board of Directors of Affinium Pharmaceuticals Inc., Profound Medical Inc. and Tioga Pharmaceuticals (observer). Mr. Lamb also serves on the Board of Directors of the Centre for Probe Development and Commercialization at McMaster University and The Health Technology Exchange (HTX). He has served on the Board of Ionalytics Corporation (acquired by Thermo Electron Corp.), Millenium Biologix (acquired by Medtronic), blueballoon Health Services Inc., and was Chairman of the Board of DELEX Therapeutics Inc. when it was sold to YM BioSciences. Mr. Lamb works closely with Genesys investee companies to strategically position them to build value for shareholders.
Prior to co-founding Genesys Capital, Mr. Lamb was an Investment Manager with MDS Capital Corp. He is a frequently invited speaker at biotechnology industry conferences and is a guest lecturer at Queen’s University School of Business.
Mr. Lamb graduated from McMaster University, Faculty of Health Sciences, with an M.S. in Molecular Neurobiology and also holds an MBA from Queen's University.
Connect with Damian:
11:30 AM | Registration, Networking and Lunch*
12:00 PM | Presentation
12:45 PM | Q&A
1:00 PM | Program Close
*Light food & beverage provided
Who should attend:
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.
There is no cost to attend this workshop, but pre-registration is required.
JLABS @ Toronto
661 University Ave, Suite 1300
Save This Event
When & Where
JLABS @ Toronto
JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.